Article
Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists.
Journal of biochemistry - 1 Aug 2009
Mukai Yohei, Nakamura Teruya, Yoshioka Yasuo, Shibata Hiroko, Abe Yasuhiro, Nomura Tetsuya, Taniai Madoka, Ohta Tsunetaka, Nakagawa Shinsaku, Tsunoda Shin-ichi, Kamada Haruhiko, Yamagata Yuriko, Tsutsumi Yasuo
Abstract excerpt
Tumour necrosis factor (TNF) is an important cytokine that induces an inflammatory response predominantly through the TNF receptor-1 (TNFR1). A crucial strategy for the treatment of many autoimmune diseases, therefore, is to block the binding of TNF to TNFR1. We previously identified a TNFR1-selective antagonistic mutant TNF (R1antTNF) from a phage library containing six randomized amino acid residues at the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
